• Recursion Pharmaceuticals’ stock rises 8% in pre-market to $5.08 after positive trial results. • The Phase 1B/2 TUPELO trial indicates significant reductions in polyp burden for REC-4881, enhancing ...

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

China’s increasing economic footprint in Brazil, Latin America’s largest economy, is redefining the region’s balance of power. Once primarily a trading partner, China is now entrenching itself in the ...

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

What is it with lawyers and AI? We don’t know, but it feels like an inordinate number of them keep screwing up with AI tools, apparently never learning from their colleagues who get publicly crucified ...

More than 40 copyright-related lawsuits have been filed in U.S. courts against developers of generative artificial intelligence (GenAI) systems. The most common complaint is that the developers ...

If a radioactive source needs to be classified in various scenarios, the required information includes identification of the radioisotope(s) present and an estimation of the activity. In the field, ...

Main Street’s not dazzled by AI’s big promises. Small businesses are testing it cautiously, leaning on features tucked into their daily software. A little over a year ago, the U.S. Chamber of Commerce ...